Beatriz S F Cury
Overview
Explore the profile of Beatriz S F Cury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira N, de Oliveira Junior E, Granja S, Boni F, Ferreira L, Cury B, et al.
Int J Pharm
. 2021 May;
603:120714.
PMID: 34015380
Mutations on the epidermal growth factor receptor (EGFR), induction of angiogenesis, and reprogramming cellular energetics are all biological features acquired by tumor cells during tumor development, and also known as...
2.
Boni F, Cury B, Ferreira N, Gremiao M
Pharmaceutics
. 2021 Apr;
13(3).
PMID: 33808670
Polymer blends of gellan gum (GG)/retrograded starch(RS) and GG/pectin (P) were cross-linked with calcium, aluminum, or both to prepare mucoadhesive microparticles as oral carriers of drugs or nano systems. Cross-linking...
3.
Ferreira L, Dos Santos A, Boni F, Dos Santos K, Robusti L, de Souza M, et al.
Carbohydr Polym
. 2020 Oct;
250:116968.
PMID: 33049864
Chitosan-based particles are widely proposed as biocompatible drug delivery systems with mucoadhesive and permeation enhancing properties. However, strategies on how to modulate the intended biological responses are still scarce. Considering...
4.
Ferreira N, Granja S, Boni F, Prezotti F, Ferreira L, Cury B, et al.
Drug Deliv Transl Res
. 2020 Jul;
10(6):1729-1747.
PMID: 32683647
Nose-to-brain delivery is a promising approach to target drugs into the brain, avoiding the blood-brain barrier and other drawbacks related to systemic absorption, and enabling an effective and safer treatment...
5.
Meneguin A, Beyssac E, Garrait G, Hsein H, Cury B
Eur J Pharm Biopharm
. 2017 Nov;
123:84-94.
PMID: 29175551
Gellan gum microparticles coated with colon-specific films based on retrograded starch and pectin was developed for enhancing the oral release of insulin (INS). The system developed promoted an impressive protection...
6.
Carbinatto F, Ribeiro T, Colnago L, Evangelista R, Cury B
J Pharm Sci
. 2015 Nov;
105(1):231-41.
PMID: 26579874
Amylose complexes with nimesulide (NMS) and praziquantel (PZQ) were prepared by a simple and low cost method, so that high yield (>57%) and drug content (up to 68.16%) were achieved....
7.
Soares G, de Castro A, Cury B, Evangelista R
Carbohydr Polym
. 2012 Oct;
91(1):135-42.
PMID: 23044114
Polymers blends represent an important approach to obtain materials with modulated properties to reach different and desired properties in designing drug delivery systems in order to fulfill therapeutic needs. The...
8.
Soares G, Carbinatto F, Cury B, Evangelista R
Drug Dev Ind Pharm
. 2012 Apr;
39(2):284-9.
PMID: 22519692
Polymers mixtures as well as cross-linking reactions are approaches that have been used successfully to modulate the polymers characteristics in order to improve the control over drug release rate. High...
9.
Physical properties of pectin-high amylose starch mixtures cross-linked with sodium trimetaphosphate
Carbinatto F, de Castro A, Cury B, Magalhaes A, Evangelista R
Int J Pharm
. 2011 Dec;
423(2):281-8.
PMID: 22178896
Pectin-high amylose starch mixtures (1:4; 1:1; 4:1) were cross-linked at different degrees and characterized by rheological, thermal, X-ray diffraction and NMR analyses. For comparison, samples without cross-linker addition were also...